Women Call Upon Congress Pull Essure from the Market

After 14 years on the market, thousands of women implanted with permanent contraceptive device Essure have come forward with concerns about the device’s side-effects. Manufactured by Bayer HealthCare, Essure works by blocking sperm to a woman’s fallopian tubes using small implanted nickel-based coils.

Krystal Donahue, a mother from Maryland who suffered painful complications after receiving the device, has spoken out about her experience with Essure. She felt constant pain in her side, exhaustion, and, as a busy mom, couldn’t sustain her normal routine. After hearing from many women about their complications from Essure, Rep. Mike Fitzpatrick (R-Pennsylvania) has turned to the FDA to push the agency to pull Essure off the market in the form of legislation dubbed the “E-Free Act.” Though the FDA has conducted reviews of Essure’s effectiveness, it remains on the market, much to the dismay of 5,000 women who have raised concerns about the device.

Real Time Analytics